2013 is the year of the “Twelfth Five-Year Plan”. Under the background of the “weak recovery” of the world economy and the slowdown of domestic macroeconomic growth, the pharmaceutical industry continued to maintain rapid growth, and its main business income exceeded 2 trillion. Key technologies such as technological innovation, quality improvement, and internationalization have also made outstanding progress, but the economic growth rate has declined, and the problems of excess drug raw materials capacity remain outstanding. The pharmaceutical industry's adjustment structure and transformation and upgrading tasks are even more important. urgent.

According to the statistics of the statistics, the added value of the pharmaceutical industry increased by 12.7% in 2013, and the growth rate dropped from 14.5% in the previous year, but it was 3.0 percentage points higher than the national industrial average. It is in the forefront of various industrial sectors and is increasing in the overall industry. The proportion of the value is increasing. From the quarterly situation, the cumulative growth rate in each quarter was 14.0%, 12.6%, 12.9%, and 12.7%, respectively. The growth was stable and there was no major fluctuation.

According to the statistics of the statistical express report, in 2013, the pharmaceutical industry's above-scale enterprises achieved a main business income of 216.16 billion yuan, a year-on-year increase of 17.9%. The main business income broke through the 2 trillion yuan mark, but the growth rate dropped by 2.5 percentage points from 20.4% in 2012, and was lower than 20% for the first time since 2007. Among the eight sub-sectors, the main business income of traditional Chinese medicine decoction pieces, pharmaceutical equipment, sanitary materials and medical supplies, and proprietary Chinese medicines was higher than the industry average growth level, and the income from the main business of biological products, medical machinery, chemical preparations, and Chemical Raw Materials increased. Faster than the industry average, chemical raw materials continued to be the slowest growing sub-sector in 2012.

In 2013, the pharmaceutical industry's above-scale enterprises realized a total profit of 219.70 billion yuan, a year-on-year increase of 17.6%, and the growth rate decreased by 2.8 percentage points compared with 2012. The operating profit margin was 10.1%, 0.03 percentage points lower than the previous year, a slight decrease. Among the eight sub-sectors, the profit margin of chemical raw materials and Chinese herbal medicines was lower than the industry average. In 2013, the profits and taxes of enterprises above designated size in the pharmaceutical industry totaled 333.63 billion yuan, a year-on-year increase of 17.6%. The number of loss-making enterprises increased by 12.8% year-on-year, and the total loss increased by 9.6% year-on-year, indicating that the company's benefits were further differentiated.

In 2013, the pharmaceutical industry's export-oriented enterprises achieved an export delivery value of 160.64 billion yuan, a year-on-year increase of 5.8%, and a growth rate of 1.5 percentage points from 2012. It is still in the single digit growth since 2012. According to customs import and export data, the export value of pharmaceuticals in 2013 was US$51.18 billion, up 6.8% year-on-year. The growth rate was 0.1 percentage points lower than that in 2012. The export volume of chemical raw materials exported to the forefront was US$23.60 billion, up 2.6% year-on-year. The export value of hospital diagnostic and therapeutic equipment was US$ 8.48 billion, a year-on-year increase of 9.5%.

Supplement

Nutritional supplements, also known as nutritional supplements, nutritional agents, dietary supplements, etc., are used as an auxiliary means of diet to supplement amino acids, trace elements, vitamins and minerals needed by the human body. Nutritional supplements can be composed of amino acids, fatty acids, minerals and vitamins, or only consists of one or a variety of vitamins, can also be composed of one or more dietary ingredients, in addition to including amino acids, vitamins, minerals and other nutrients, also can have herbs or other plant components, or more ingredients of concentrate, extract or combination.Nutritional supplements, also known as dietary supplements, nutritional supplements, nutritional agents, dietary supplements, etc., are used as an auxiliary means of diet to supplement amino acids, trace elements, vitamins and minerals needed by the human body.we have Alpha GPC 50%,Tototrienol,7 8-Dihydroxyflavone,Palmitoylethanolamide Granular ,RU58841,1-1-Adamantylcarbonyl proline ACA,Galantamine Hydrobromide,Nooglutyl,Tianeptine Sodium,Oleoylethanolamide OEA,Sunifiram,Oleamide ODA,N-Dodecanoyl-L-Proline.

Alpha GPC 50%,Tototrienol,7 8-Dihydroxyflavone,Palmitoylethanolamide Granular,RU58841.

Xi'an Henrikang Biotech Co.,Ltd , https://www.henrikangbio.com